EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
SCYE1 |
SCYE1, EMAP2: Multisynthetase complex auxiliary component p43 [Contains: Endothe |
28.2 |
Evidence |
|
SNRPD2 |
SNRPD2, SNRPD1: Small nuclear ribonucleoprotein Sm D2 |
RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
28.2 |
Evidence |
|
WDR68 |
WDR68, HAN11: WD repeat-containing protein 68 |
LSM3 |
LSM3, MDS017: U6 snRNA-associated Sm-like protein LSm3 |
28.2 |
Evidence |
|
F2 |
F2: Prothrombin precursor |
CNTN2 |
CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor |
28.170 |
Evidence |
|
PROC |
PROC: Vitamin K-dependent protein C precursor |
SLC37A4 |
G6PC, G6PT: Glucose-6-phosphatase |
28.170 |
Evidence |
|
HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
NEU1 |
NEU1, NANH: Sialidase-1 precursor |
28.080 |
Evidence |
|
HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
28.080 |
Evidence |
|
HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
CRKL |
CRKL: Crk-like protein |
28.080 |
Evidence |
|
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
28.080 |
Evidence |
|
NME1 |
NME1, NDPKA, NM23: Nucleoside diphosphate kinase A |
RAN |
RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran |
28.010 |
Evidence |
|
PLG |
PLG: Plasminogen precursor |
RNASE4 |
ANG, RNASE5: Angiogenin precursor |
28.010 |
Evidence |
|
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
C3 |
|
28.010 |
Evidence |
|
IL1B |
IL1B, IL1F2: Interleukin-1 beta precursor |
MMP1 |
MMP1, CLG: Interstitial collagenase precursor |
28.010 |
Evidence |
|
RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
NEK9 |
NEK9, KIAA1995, NEK8, NERCC: Serine/threonine-protein kinase Nek9 |
28.010 |
Evidence |
|
PLG |
PLG: Plasminogen precursor |
ALB |
ALB: Uncharacterized protein ALB |
28.010 |
Evidence |
|
TF |
TF, PRO1400: Serotransferrin precursor |
VTN |
VTN: Vitronectin precursor |
28.010 |
Evidence |
|
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
DEF6 |
DEF6, IBP: Differentially expressed in FDCP 6 |
28.010 |
Evidence |
|
CFB |
CFB, BF, BFD: Complement factor B precursor |
HRG |
HRG: Histidine-rich glycoprotein precursor |
28.010 |
Evidence |
|
HRG |
HRG: Histidine-rich glycoprotein precursor |
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
28.010 |
Evidence |
|
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
IFI16 |
IPI00217474 |
28.010 |
Evidence |
|
AGT |
AGT, SERPINA8: Angiotensinogen precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
28.010 |
Evidence |
|
CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
28.010 |
Evidence |
|
CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
CASP8 |
IPI00305242 |
28.010 |
Evidence |
|
ESPL1 |
IPI00397474 |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
28.010 |
Evidence |
|
AGT |
AGT, SERPINA8: Angiotensinogen precursor |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
28.010 |
Evidence |
|